Wedbush Maintains Outperform on Solventum, Raises Price Target to $101

Benzinga Newsdesk www.benzinga.com Positive 90.5%

Neg 0% Neu 0% Pos 90.5%

Wedbush analyst Michael Piccolo maintains Solventum (NYSE:SOLV) with a Outperform and raises the price target from $94 to $101.